Table 9.
Drugs with Black Box warnings for hepatotoxicity.35) A “Black Box” warning is the strongest type of warning that the U. S. Food and Drug Administration can require for a drug and is generally reserved for warning prescribers about adverse drug reactions that can cause serious injury or death. At issue here is the benefit/risk ratio.
Drug | Dose (mg/day) | Reactive products | Reference |
---|---|---|---|
Acitretin | 25–50 | No | |
Bosentan | 125–250 | No | |
Dacarbazine | 140–315 | Yes | 47) |
Dantrolene | 300–400 | Yes | 48) |
Felbamate | 1200 | Yes | 49) |
Flutamide | 750 | Yes | 50) |
Gemtuzumab | (9 mg m−3) | Yes (?) | 51) |
Isoniazid | 300 | Yes | 52) |
Ketoconazole | 200 | Yes | 53) |
Naltrexone | 50 | No | |
Nevirapine | 200 | Yes | |
Tolcapone | 300 | Yes | 54) |
Trovafloxacin | 100–500 | No | |
Valporic acid | 1000–2400 | Yes | 55) |
10/14 = 71% |